$94.97 0.00 (0%)
3/26/2009 4:00 PM

Genentech, Inc. (NYSE:DNA.DL)

CAPS Rating: No stars

The Company is a biotechnology company that discovers, develops, manufactures, and commercializes biotherapeutics for unmet medical needs.

No one has written a Pitch for DNA.DL yet. Tell us why you think DNA.DL will outperform or underperform the market.

Featured Broker Partners


Advertisement